Product Details for NDA 050808
SOLODYN (MINOCYCLINE HYDROCHLORIDE)
EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
EQ 55MG BASE
Marketing Status: Discontinued
EQ 65MG BASE
Marketing Status: Discontinued
EQ 80MG BASE
Marketing Status: Discontinued
EQ 90MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
EQ 105MG BASE
Marketing Status: Discontinued
EQ 115MG BASE
Marketing Status: Discontinued
EQ 135MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: MINOCYCLINE HYDROCHLORIDE
Proprietary Name: SOLODYN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050808
Product Number: 001
Approval Date: May 8, 2006
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
SOLODYN (MINOCYCLINE HYDROCHLORIDE)
Proprietary Name: SOLODYN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050808
Product Number: 001
Approval Date: May 8, 2006
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 55MG BASE
Marketing Status: Discontinued
Active Ingredient: MINOCYCLINE HYDROCHLORIDE
Proprietary Name: SOLODYN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 55MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050808
Product Number: 008
Approval Date: Aug 27, 2010
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
SOLODYN (MINOCYCLINE HYDROCHLORIDE)
Proprietary Name: SOLODYN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 55MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050808
Product Number: 008
Approval Date: Aug 27, 2010
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 65MG BASE
Marketing Status: Discontinued
Active Ingredient: MINOCYCLINE HYDROCHLORIDE
Proprietary Name: SOLODYN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 65MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050808
Product Number: 004
Approval Date: Jul 23, 2009
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
SOLODYN (MINOCYCLINE HYDROCHLORIDE)
Proprietary Name: SOLODYN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 65MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050808
Product Number: 004
Approval Date: Jul 23, 2009
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 80MG BASE
Marketing Status: Discontinued
Active Ingredient: MINOCYCLINE HYDROCHLORIDE
Proprietary Name: SOLODYN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 80MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050808
Product Number: 007
Approval Date: Aug 27, 2010
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
SOLODYN (MINOCYCLINE HYDROCHLORIDE)
Proprietary Name: SOLODYN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 80MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050808
Product Number: 007
Approval Date: Aug 27, 2010
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 90MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: MINOCYCLINE HYDROCHLORIDE
Proprietary Name: SOLODYN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 90MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050808
Product Number: 002
Approval Date: May 8, 2006
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
SOLODYN (MINOCYCLINE HYDROCHLORIDE)
Proprietary Name: SOLODYN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 90MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050808
Product Number: 002
Approval Date: May 8, 2006
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 105MG BASE
Marketing Status: Discontinued
Active Ingredient: MINOCYCLINE HYDROCHLORIDE
Proprietary Name: SOLODYN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 105MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050808
Product Number: 006
Approval Date: Aug 27, 2010
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
SOLODYN (MINOCYCLINE HYDROCHLORIDE)
Proprietary Name: SOLODYN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 105MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050808
Product Number: 006
Approval Date: Aug 27, 2010
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 115MG BASE
Marketing Status: Discontinued
Active Ingredient: MINOCYCLINE HYDROCHLORIDE
Proprietary Name: SOLODYN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 115MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050808
Product Number: 005
Approval Date: Jul 23, 2009
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
SOLODYN (MINOCYCLINE HYDROCHLORIDE)
Proprietary Name: SOLODYN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 115MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050808
Product Number: 005
Approval Date: Jul 23, 2009
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 135MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: MINOCYCLINE HYDROCHLORIDE
Proprietary Name: SOLODYN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 135MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050808
Product Number: 003
Approval Date: May 8, 2006
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: SOLODYN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 135MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050808
Product Number: 003
Approval Date: May 8, 2006
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information